Table 3 Comparison of laboratory measures between the two improved and non-improved groups undergoing the study intervention
Variable | Improved patients (N = 6) | Non-improved patients (N = 4) | p-value (t-test) |
|---|---|---|---|
Mean age (year) | 55.33 ± 21.38 | 60.25 ± 14.10 | 0.699 |
Baseline white blood cell count (× 109/L) | 8900.00 ± 3204.99 | 15,225.00 ± 7125.71 | 0.088 |
Baseline percentage of plasma lymphocytes (%) | 8.90 ± 3.58 | 3.48 ± 1.96 | 0.038 |
Serum hemoglobin (mg/dL) | 11.05 ± 1.69 | 11.30 ± 1.80 | 0.829 |
Serum platelet count (× 109/L) | 241,833.33 ± 139,053.11 | 236,250.00 ± 78,415.03 | 0.944 |
Serum c-reactive protein (mg/L) | 152.00 ± 100.07 | 110.00 ± 56.93 | 0.538 |
Serum lactate dehydrogenase (U/L) | 819.67 ± 116.17 | 1400.00 ± 353.55 | 0.066 |
Blood urea nitrogen (mg/dL) | 30.50 ± 22.16 | 51.50 ± 36.35 | 0.284 |
Serum creatinine (mg/dL) | 1.23 ± 0.88 | 1.90 ± 1.65 | 0.425 |
Serum aspartate aminotransferase (SGOT) (U/L) | 68.00 ± 26.00 | 41.75 ± 13.91 | 0.141 |
Serum alanine aminotransferase (SGPT) (U/L) | 52.00 ± 19.97 | 28.25 ± 8.96 | 0.083 |
Serum IL-6 (ng/mL) | 122.83 ± 76.49 | 165.00 ± 149.29 | 0.568* |